Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Lineage Cell Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +1 vs. Q2 2021
- Shares held
- 75.8M
- +2.70M (+3.7%) vs. Q2 2021
- Total value
- $191.7M
- −$16.7M (−8.0%) vs. Q2 2021
- New holders
- 15
- 27 more added
- Sold out
- 14
- 35 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fifth Third Bancorp | 1,420 | $4.00K | 0.00% | 00.0% | Unchanged |
| Concord Wealth Partners | 1,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Archer Investment Corp | 1,000 | $2.52K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 678 | $2.00K | 0.00% | −58−7.9% | Reduced |
| Glen Eagle Advisors, LLC | 500 | $1.26K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 396 | $1.00K | 0.00% | −144−26.7% | Reduced |
| Godsey & Gibb Associates | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Community Bank, N.A. | 508 | $1.00K | 0.00% | +508 | New |
| First Manhattan Co | 94 | $0 | 0.00% | −2,000−95.5% | Reduced |
| Central Trust Co | 29 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 2 | $0 | 0.00% | −3−60.0% | Reduced |
| Assetmark, Inc | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 8 | $0 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Gerber Kawasaki Wealth & Investment Management | 1 | – | – | +1 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −186,940−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −54,131−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −47,500−100.0% | Sold out |
| Quilter Plc | 0 | $0 | 0.00% | −24,873−100.0% | Sold out |
| Paradigm, Strategies in Wealth Management, LLC | 0 | $0 | 0.00% | −19,775−100.0% | Sold out |
| Wealth Architects, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −13,482−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −9,100−100.0% | Sold out |
| Credential Qtrade Securities Inc. | 0 | $0 | 0.00% | −2,920−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Credit Agricole S A | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Iron Horse Wealth Management, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| McClarren Financial Advisors, Inc. | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Bel Air Investment Advisors LLC | – | – | – | – | Not filed |